Cargando…
Infrequent mutation of the tumour-suppressor gene Smad4 in early-stage colorectal cancer
Smad4 is a candidate tumour-suppressor gene identified recently on chromosome 18q21.1. Both alleles are inactivated in nearly one-half of pancreatic carcinomas, but its role in the tumorigenesis of other tumours is still unknown. The aim of this study was to investigate the potential involvement of...
Autores principales: | Mamot, C, Mild, G, Reuter, J, Laffer, U, Metzger, U, Terracciano, L, Boulay, J-L, Herrmann, R, Rochlitz, C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747552/ https://www.ncbi.nlm.nih.gov/pubmed/12569386 http://dx.doi.org/10.1038/sj.bjc.6600733 |
Ejemplares similares
-
SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer
por: Boulay, J-L, et al.
Publicado: (2002) -
SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer
por: Boulay, J-L, et al.
Publicado: (2003) -
Loss of HOP tumour suppressor expression in head and neck squamous cell carcinoma
por: Lemaire, F, et al.
Publicado: (2004) -
The coxsackievirus and adenovirus receptor acts as a tumour suppressor in malignant glioma cells
por: Kim, M, et al.
Publicado: (2003) -
Prognostic impact of chromosomal aberrations in Ewing tumours
por: Hattinger, C M, et al.
Publicado: (2002)